title: First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
abstract: This is the first documented case of a drug-coated balloon strategy for the treatment of bioresorbable in-scaffold restenosis caused by diffuse neointimal proliferation. This case can provide an alternative treatment option in this setting, avoiding potential problems related to further bulky metallic stents in a patient where a different strategy was initially planned. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Department of Interventional Cardiology, ASST Fatebenefratelli Sacco, Milan, Italy.
authors.forename: Roberto Adriano
authors.initials: RA
authors.lastname: Latini
authors.affiliation: Department of Interventional Cardiology, University Hospital, Policlinic "P.Giaccone" Palermo, Italia.
authors.forename: Dario
authors.initials: D
authors.lastname: Buccheri
authors.affiliation: Department of Interventional Cardiology, ASST Fatebenefratelli Sacco, Milan, Italy.|Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Massa, Italy.
authors.forename: Bernardo
authors.initials: B
authors.lastname: Cortese
mesh_terms: D020341:Absorbable Implants; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000175:diagnosis / Q000601:surgery*; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000601:surgery*; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D011474:Prosthesis Design; D020123:Sirolimus / Q000494:pharmacology*; D054457:Tissue Scaffolds; D041623:Tomography, Optical Coherence; D018084:Ultrasonography, Interventional
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus
keywords: BVS; DCB; OCT; in-scaffold restenosis